Postanalytical external quality assessment of urine albumin in primary health care: An international survey

Clinical Chemistry

Volumn 54, Issue 10, 2008, Pages 1630-1636

  Aakre, Kristin M ^a   Thue, Geir ^b   Subramaniam Haavik, Sumathi ^b   Bukve, Tone ^b   Morris, Howard ^c   Müller, Mathias ^d   Lovrencic, Marijana V ^e   Plum, Inger ^f   Kallion, Kaja ^g   Aab, Alar ^g   Kutt, Marge ^h   Gillery, Philippe ⁱ   Schneider, Nathalie ⁱ   Horvath, Andrea R ^j   Onody, Rita ^j   Oosterhuis, Wytze ^k   Ricos, Carmen ^l   Perich, Carmen ^m   Nordin, Gunnar ⁿ   Sandberg, Sverre ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d KAISER FRANZ JOSEF HOSPITAL   (Austria)

^e University of Zagreb   (Croatia)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF TARTU   (Estonia)

^h East Tallinn Central Hospital   (Estonia)

ⁱ AMERICAN MEMORIAL HOSPITAL   (France)

^j UNIVERSITY OF SZEGED   (Hungary)

^k CPRLab   (Netherlands)

^l Laboratori Clinic Bon Pastor   (Spain)

^m Sociedad Espanola de Bioquimica Clinica y Patologia Molecular   (Spain)

ⁿ External Quality Assurance in Laboratory Medicine in Sweden   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ARTICLE; GENERAL PRACTITIONER; HUMAN; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIMARY HEALTH CARE; QUESTIONNAIRE; URINALYSIS; URINE; ALBUMINURIA; AUSTRALIA; EUROPE; INTERNATIONAL COOPERATION; LABORATORY DIAGNOSIS; QUALITY CONTROL;

ALBUMINURIA; AUSTRALIA; DIABETES MELLITUS, TYPE 2; EUROPE; HUMANS; INTERNATIONALITY; PRIMARY HEALTH CARE; QUALITY CONTROL; QUESTIONNAIRES; SPECIMEN HANDLING;

EID: 54049154749     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.100917     Document Type: Article

References (27)

1. World Health Organization. Fact Sheet N 312. Diabetes. http://www.who.int/mediacentre/fact sheets/fs312/en/index.html (Accessed October 2007).
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
3. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess 2005;9:iii-vi, xiii-163.
4. Scottish Intercollegiate Guidelines Network. SIGN Publication No. 55. Management of Diabetes. Section 5: Management of diabetic nephropathy. http://www.sign.ac.uk/guidelines/published/index. html#Diabetes (Accessed October 2007).
5. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2006;29:S4-42.
6. International Diabetes Federation. Global Guideline for Type 2 Diabetes. http://www.idf.org/ home/index.cfm?unode=B7462CCB-3A4C-472C-80E4-710074D74AD3 (Accessed October 2007).
7. National Institute for Health and Clinical Excellence. Clinical Guideline F Management of type 2 diabetes: renal disease-prevention and early management. http://guidance.nice.org.uk/CGF/? c=91500 (Accessed October 2007).
8. Zanchetti A. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
9. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67: 2089-100.
10. Skeie S, Perich C, Ricos C, Araczki A, Horvath AR, Oosterhuis WP, et al. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey. Clin Chem 2005;51:1145-53.
11. Harris SB, Stewart M, Brown JB, Wetmore S, Faulds C, Webster-Bogaert S, Porter S. Type 2 diabetes in family practice. Room for improvement. Can Fam Physician 2003;49:778-85.
12. Fagnani F, Souchet T, Labed D, Gaugris S, Hannedouche T, Grimaldi A. Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France - 2001). Diabetes Metab 2003;29:58-64.
13. Mainous AG 3rd, Gill JM. The lack of screening for diabetic nephropathy: evidence from a privately insured population. Fam Med 2001;33: 115-9.
14. Hueston WJ, Scibelli S, Mainous IA. Use of microalbuminuria testing in persons with type 2 diabetes: are the right patients being tested? J Fam Pract 2001;50:669-73.
15. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
16. Gansevoort RT, Brinkman J, Bakker SJ, De Jong PE, de Zeeuw D. Evaluation of measures of urinary albumin excretion. Am J Epidemiol 2006; 164:725-7.
17. Drass J, Kell S, Osborn M, Bausell B, Corcoran J Jr, Moskowitz A, Fleming B. Diabetes care for Medicare beneficiaries: attitudes and behaviors of primary care physicians. Diabetes Care 1998;21: 1282-7.
18. Chasuk RM, Brantley PJ, Martin PD. Knowledge and attitudes of family physicians about clinical practice guidelines and the care of patients with type 2 diabetes mellitus. J La State Med Soc 2001;153:31-44.
19. Ratsep A, Kalda R, Oja I, Lember M. Family doctors' knowledge and self-reported care of type 2 diabetes patients in comparison to the clinical practice guideline: cross-sectional study. BMC Fam Pract 2006;7:36.
20. Wong T, Foote EF, Lefavour GS, Cody RP, Brown CJ, Sherman RA. Physician knowledge and practice patterns relating to diabetic nephropathy. J Am Pharm Assoc (Wash) 1999;39:785-90.
21. Agence Nationale d'Accréditation et d'Evaluation en Santé Diagnostic de l'insuffisance rénale chronique chez l'adulte Synthèse des recommandations. http://www.has-sante.fr/portail/display. jsp?id=c_272222 (Accessed October 2007).
22. Lawler FH, Viviani N. Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Pract 1997;44:369-73.
23. Collins AC, Vincent J, Newall RG, Mitchell KM, Viberti GC. An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic. Diabet Med 2001; 18:928-32.
24. Parsons MP, Newman DJ, Newall RG, Price CP. Validation of a point-of-care assay for the urinary albumin:creatinine ratio. Clin Chem 1999;45: 414-7.
25. Shephard MD, Allen GG, Paizis K, Barbara JA, Batterham M, Vanajek A. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio. Rural Remote Health 2006;6:591.
26. Medicines and Healthcare products Regulatory Agency. MHAR 04086 Point of care devices for the quantitation of microalbuminuria. http:// www.pasa.nhs.uk/pasa/Doc.aspx?Path=[MN][SP]/ NHSprocurement/CEP/Biochemistry/ MHRA% 2004086.pdf (Accessed October 2007).
27. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.